𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

✍ Scribed by T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Imanaka; A. Yamada; M. Oshita; H. Hagiwara; E. Mita; T. Ito; Y. Inui; T. Hijioka; S. Tamura; H. Yoshihara; E. Hayashi; A. Inoue; Y. Imai; M. Kato; Y. Yoshida; T. Tatsumi; K. Ohkawa; S. Kiso; T. Kanto; A. Kasahara; T. Takehara; N. Hayashi

Book ID
108886268
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
175 KB
Volume
16
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon alpha-2b plus ribav
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated